Neos Therapeutics, Inc. NEOS
Set alert
No live quote for NEOS yet.
- Open
- 1.16
- Prev close
- 1.18
- Mkt cap
- 57.22M
- Vol
- 15.01M
- Avg vol
- 7.10M
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.06
- High
- 1.18
- Forward P/E
- -19.17
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.9922
- 200-d avg
- 0.733477
- 1y target
- 1.00
Analyst view
Consensus: buy
Buy
Price target (mean) 1.00
Ratings (0m) 6 5 buy · 1 hold · 0 sell
- Strong buy1
- Buy4
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 1
- 2 months ago 1
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.07 | +100.0% | 19.10M | +13.5% | 1 |
| Current year | -0.37 | -0.37 – -0.37 | -0.34 | -8.8% | 59.30M | -8.3% | 1 |
| Next year | -0.06 | -0.06 – -0.06 | -0.37 | +83.8% | 77.80M | +31.2% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 11, 2019 | BMO Capital | Maintained | — | Market Perform |
| Nov 11, 2018 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Aug 8, 2018 | Wells Fargo | Maintained | Outperform | Outperform |
| Jan 30, 2018 | BMO Capital | Downgrade | Outperform | Market Perform |
| Jul 31, 2017 | Cantor Fitzgerald | Initiated | — | Overweight |
| Apr 4, 2017 | Cowen & Co. | Initiated | — | Outperform |
| Mar 19, 2017 | UBS | Downgrade | Buy | Neutral |
| Jun 28, 2016 | BMO Capital | Initiated | — | Outperform |
| Mar 8, 2016 | JMP Securities | Maintained | — | Market Outperform |
| Feb 18, 2016 | Wells Fargo | Initiated | — | Outperform |
| Aug 16, 2015 | RBC Capital | Initiated | — | Outperform |
| Aug 16, 2015 | BMO Capital | Initiated | — | Outperform |
| Aug 16, 2015 | JMP Securities | Initiated | — | Market Outperform |